Sign in

    Raji Parik • Barclays

    Raji Parik is a Vice President and Equity Research Analyst at Barclays, specializing in consumer retail and e-commerce sector coverage with a focus on leading companies such as Walmart, Target, Amazon, and Costco. Parik is recognized for delivering insightful fundamental analysis and has been noted on industry platforms for maintaining a success rate of approximately 63% and generating strong returns with an average annualized return of over 8% per recommendation. Since joining Barclays in 2019, Parik has established a robust track record, drawing from prior experience in equity research roles at firms such as J.P. Morgan and Deutsche Bank, and holds active FINRA Series 7, 63, and 86/87 certifications. Known for sharp market insight and data-driven research, Parik is regarded as a rising talent in Wall Street analyst rankings for the retail equity space.

    Raji Parik's questions to Lavoro Ltd (LVRO) leadership

    Raji Parik's questions to Lavoro Ltd (LVRO) leadership • Q3 2024

    Question

    Asked about the future pricing strategy for biologicals and the competitive landscape, specifically whether competitors are also lowering prices to drive sales.

    Answer

    The company does not anticipate further significant price reductions for biologicals. Past discounts were influenced by depressed agrochemical prices. The expectation is for prices to stabilize and potentially recover as the broader agrochemical market improves.

    Ask Fintool Equity Research AI

    Raji Parik's questions to Lavoro Ltd (LVRO) leadership • Q3 2024

    Question

    An analyst from Barclays inquired about the biologicals business, asking if Lavoro anticipates further price reductions to drive volume or if pricing will stabilize, and what competitive pricing trends are being observed.

    Answer

    CEO Ruy Cunha responded that he does not expect significant further discounts for biologicals. He explained that past price reductions were linked to depressed agrochemical prices, but he now sees this trend stabilizing and believes there is potential for price recovery as the broader agrochemical market improves.

    Ask Fintool Equity Research AI

    Raji Parik's questions to Lavoro Ltd (LVRO) leadership • Q3 2024

    Question

    Raji Parik from Barclays inquired about the pricing strategy for biologicals, asking if Lavoro plans to continue offering discounts to gain volume or if prices are expected to stabilize. He also asked about the competitive landscape and whether peers are similarly lowering prices.

    Answer

    CEO Ruy Cunha stated that he does not anticipate further significant discounts for biologicals. He explained that past price reductions were influenced by the depressed prices of traditional agrochemicals, to which their biologicals are related, and farmer demand for lower prices. Cunha believes this trend is now stabilizing and sees a potential for price recovery as the agrochemical market improves.

    Ask Fintool Equity Research AI